No. |
Author |
Title |
Source |
Paper No.* |
FME Affiliation(s) |
URL |
Full citation |
1 | Alejos B., Croft K.R., Jiao Y., Wolf M., Carioni P., Soni M., Winter A., Neri L., Chaudhuri S., Singh K., Stuard S., Nikam M., Guinsburg A.M., Chatoth D.K., Hymes J.L., Koulechov K., Usvyat L.A., Larkin J.W. and Maddux F.W. | Cardiovascular Morbidity Patterns in Patients on Dialysis Globally in Apollo Dial DB | J Am Soc Nephrol 35, 2024: FR-PO368 | FR-PO368 | Fresenius Medical Care | Read More | Alejos B., Croft K.R., Jiao Y., Wolf M., Carioni P., Soni M., Winter A., Neri L., Chaudhuri S., Singh K., Stuard S., Nikam M., Guinsburg A.M., Chatoth D.K., Hymes J.L., Koulechov K., Usvyat L.A., Larkin J.W. and Maddux F.W.: Cardiovascular Morbidity Patterns in Patients on Dialysis Globally in Apollo Dial DB J Am Soc Nephrol 35, 2024: FR-PO368. |
2 | Alejos B., Croft K.R., Winter A., Guinsburg A.M., Hymes J.L., Larkin J.W., Usvyat L.A., Guinsburg M.E. and Maddux F.W. | Comparison of Clinical and Sociodemographic Characteristics of Hemodialysis Modalities | J Am Soc Nephrol 35, 2024: FR-PO1036 | FR-PO1036 | Fresenius Medical Care | Read More | Alejos B., Croft K.R., Winter A., Guinsburg A.M., Hymes J.L., Larkin J.W., Usvyat L.A., Guinsburg M.E. and Maddux F.W.: Comparison of Clinical and Sociodemographic Characteristics of Hemodialysis Modalities J Am Soc Nephrol 35, 2024: FR-PO1036. |
3 | Alvarez H.Q., Claudio-Rodriguez C., Peguero J.A. and Hernandez-Arroyo C.F. | Closure of an Endovascular Arteriovenous Fistula Initially Created for Dialysis Access by Placement of Radial Artery Covered Stent | J Am Soc Nephrol 35, 2024: FR-PO530 | FR-PO530 | Azura Vascular Care | Read More | Alvarez H.Q., Claudio-Rodriguez C., Peguero J.A. and Hernandez-Arroyo C.F.: Closure of an Endovascular Arteriovenous Fistula Initially Created for Dialysis Access by Placement of Radial Artery Covered Stent J Am Soc Nephrol 35, 2024: FR-PO530. |
4 | Ban A.N., Filardi V., Wang L.-C., Ye X., Kotanko P. and Zhang H. | Change of Central Venous Oxygen Saturation during Hemodialysis: A Real-Time Window into Intradialytic Hemodynamics | J Am Soc Nephrol 35, 2024: SA-PO417 | SA-PO417 | Renal Research Institute | Read More | Ban A.N., Filardi V., Wang L.-C., Ye X., Kotanko P. and Zhang H.: Change of Central Venous Oxygen Saturation during Hemodialysis: A Real-Time Window into Intradialytic Hemodynamics J Am Soc Nephrol 35, 2024: SA-PO417. |
5 | Batte A., Bassat Q., Kotanko P., Raimann J.G. and Conroy A.L. | Saliva Urea Nitrogen Improves Mortality Prediction in Children with Malnutrition and AKI | J Am Soc Nephrol 35, 2024: FR-PO049 | FR-PO049 | Renal Research Institute | Read More | Batte A., Bassat Q., Kotanko P., Raimann J.G. and Conroy A.L.: Saliva Urea Nitrogen Improves Mortality Prediction in Children with Malnutrition and AKI J Am Soc Nephrol 35, 2024: FR-PO049. |
6 | Braun J., Pham N., Cromm K., Maierhofer A. and Stauss-Grabo M. | Comparison of Individualized Sodium Management vs. Standard Treatment in Hemodialysis: The SODIAH Study | J Am Soc Nephrol 35, 2024: SA-PO413 | SA-PO413 | Fresenius Medical Care | Read More | Braun J., Pham N., Cromm K., Maierhofer A. and Stauss-Grabo M.: Comparison of Individualized Sodium Management vs. Standard Treatment in Hemodialysis: The SODIAH Study J Am Soc Nephrol 35, 2024: SA-PO413. |
7 | Bregoli A., Bellocchio F., Maierhofer A., Hymes J.L., Usvyat L.A., Neri L. and Stella F. | Arteriovenous Fistula Failure Prediction Using Single Treatment Information | J Am Soc Nephrol 35, 2024: FR-PO523 | FR-PO523 | Fresenius Medical Care | Read More | Bregoli A., Bellocchio F., Maierhofer A., Hymes J.L., Usvyat L.A., Neri L. and Stella F.: Arteriovenous Fistula Failure Prediction Using Single Treatment Information J Am Soc Nephrol 35, 2024: FR-PO523. |
8 | Canziani M.E.F., Strogoff-de-Matos J.P. and Barra A.B.L. | Mortality Risk on Hemodiafiltration Compared with High-Flux Hemodialysis: Real-World Evidence from a Large Brazilian Cohort | J Am Soc Nephrol 35, 2024: FR-OR20 | FR-OR20 | Fresenius Medical Care | Read More | Canziani M.E.F., Strogoff-de-Matos J.P. and Barra A.B.L.: Mortality Risk on Hemodiafiltration Compared with High-Flux Hemodialysis: Real-World Evidence from a Large Brazilian Cohort J Am Soc Nephrol 35, 2024: FR-OR20. |
9 | Caroline Yovanovich, Weller R.B., Kotanko P. and Wang Y. | Blood Pressure-Lowering Effects of Ultraviolet Light in Patients on Hemodialysis: Identification of Specific Wavelengths | J Am Soc Nephrol 35, 2024: SA-PO410 | SA-PO410 | Renal Research Institute | Read More | Caroline Yovanovich, Weller R.B., Kotanko P. and Wang Y.: Blood Pressure-Lowering Effects of Ultraviolet Light in Patients on Hemodialysis: Identification of Specific Wavelengths J Am Soc Nephrol 35, 2024: SA-PO410. |
10 | Chan C., Zhang Y., Cheung Y.Y., Mooppil N., Singh T., Winter A., Maddux F.W., Hymes J.L. and Nikam M. | Hemodiafiltration Is Associated with Lower Hospitalization Rates Compared with Hemodialysis in a Singapore Cohort | J Am Soc Nephrol 35, 2024: TH-PO236 | TH-PO236 | Fresenius Medical Care | Read More | Chan C., Zhang Y., Cheung Y.Y., Mooppil N., Singh T., Winter A., Maddux F.W., Hymes J.L. and Nikam M.: Hemodiafiltration Is Associated with Lower Hospitalization Rates Compared with Hemodialysis in a Singapore Cohort J Am Soc Nephrol 35, 2024: TH-PO236. |
11 | Chan C., Zhang Y., Cheung Y.Y., Mooppil N., Singh T., Winter A., Maddux F.W., Hymes J.L. and Nikam M. | Adequate Convective Volume Can Be Achieved in Majority of Multiethnic Asian Patients Receiving Hemodiafiltration in Singapore | J Am Soc Nephrol 35, 2024: TH-PO235 | TH-PO235 | Fresenius Medical Care | Read More | Chan C., Zhang Y., Cheung Y.Y., Mooppil N., Singh T., Winter A., Maddux F.W., Hymes J.L. and Nikam M.: Adequate Convective Volume Can Be Achieved in Majority of Multiethnic Asian Patients Receiving Hemodiafiltration in Singapore J Am Soc Nephrol 35, 2024: TH-PO235. |
12 | Chaudhuri S., Willetts J., Halliday T., Hosey M., Usvyat L.A. and Maddux F.W. | Improving Treatment Adherence in Patients on In-Center Hemodialysis through Daily Targeted Reporting and Intervention | J Am Soc Nephrol 35, 2024: TH-PO300 | TH-PO300 | Fresenius Medical Care | Read More | Chaudhuri S., Willetts J., Halliday T., Hosey M., Usvyat L.A. and Maddux F.W.: Improving Treatment Adherence in Patients on In-Center Hemodialysis through Daily Targeted Reporting and Intervention J Am Soc Nephrol 35, 2024: TH-PO300. |
13 | Cromm K., Pham N., Tunçel Ö.K., Humpert M., Ríos T.D.l., Stauss-Grabo M., Asci G., Ok E. and Elbi H. | Self-Efficacy Predicts Patient-Reported Outcomes Measurement Information System (PROMIS) Health-Related Quality of Life Outcomes in Turkish Patients on Dialysis Better than the 36-Item Short Form Health Survey (SF-36) | J Am Soc Nephrol 35, 2024: PUB153 | PUB153 | Fresenius Medical Care | Read More | Cromm K., Pham N., Tunçel Ö.K., Humpert M., Ríos T.D.l., Stauss-Grabo M., Asci G., Ok E. and Elbi H.: Self-Efficacy Predicts Patient-Reported Outcomes Measurement Information System (PROMIS) Health-Related Quality of Life Outcomes in Turkish Patients on Dialysis Better than the 36-Item Short Form Health Survey (SF-36) J Am Soc Nephrol 35, 2024: PUB153. |
14 | Daugirdas J.T., Mermelstein A.E., Wang Y., Raimann J.G. and Kotanko P. | Associations of Blood Water Cleared during a Dialysis Session Scaled to Body Surface Area with Weight-Specific Mortality Risk | J Am Soc Nephrol 35, 2024: TH-PO319 | TH-PO319 | Renal Research Institute | Read More | Daugirdas J.T., Mermelstein A.E., Wang Y., Raimann J.G. and Kotanko P.: Associations of Blood Water Cleared during a Dialysis Session Scaled to Body Surface Area with Weight-Specific Mortality Risk J Am Soc Nephrol 35, 2024: TH-PO319. |
15 | Deleaval P., Penny J.D., Freeman A. and McIntyre C.W. | Initial Feasibility Pilot Study of Interdialytic Peritoneal Ultrafiltration to Manage Volume Status in Patients on Hemodialysis (iPUF-HD) | J Am Soc Nephrol 35, 2024: SA-PO450 | SA-PO450 | Nephrocare | Read More | Deleaval P., Penny J.D., Freeman A. and McIntyre C.W.: Initial Feasibility Pilot Study of Interdialytic Peritoneal Ultrafiltration to Manage Volume Status in Patients on Hemodialysis (iPUF-HD) J Am Soc Nephrol 35, 2024: SA-PO450. |
16 | Derek M. Blankenship and Kraus M.A. | Longitudinal Assessment of Clinical Outcomes for Transitional Care Units | J Am Soc Nephrol 35, 2024: TH-PO259 | TH-PO259 | Fresenius Medical Care | Read More | Derek M. Blankenship and Kraus M.A.: Longitudinal Assessment of Clinical Outcomes for Transitional Care Units J Am Soc Nephrol 35, 2024: TH-PO259. |
17 | Dias G.F., Fan C., Han M., Wang X., Wang X., Zhang H., Grobe N., Guo W., Kotanko P., Wang Y. and Renal Research Institute’s Laboratory Research | Metabolomics Profile of Hemodialysis Patients during the COVID-19 Putative Incubation Period | J Am Soc Nephrol 35, 2024: TH-PO1163 | TH-PO1163 | Renal Research Institute | Read More | Dias G.F., Fan C., Han M., Wang X., Wang X., Zhang H., Grobe N., Guo W., Kotanko P., Wang Y. Renal Research Institute’s Laboratory Research: Metabolomics Profile of Hemodialysis Patients during the COVID-19 Putative Incubation Period J Am Soc Nephrol 35, 2024: TH-PO1163. |
18 | Dong Z., Zhang H., Wang L.-C., Ren S., Han M., Tisdale L., Bittencourt V.G., Rosales L., Starakiewicz P., Douglas D., Shtaynberg N., Kozyra A., Fuca N., Prakash-Polet S., Thijssen S., Preddie D.C. and Kotanko P. | Validation of a Cloud-Based Convolutional Neural Network Classifying Arteriovenous Access Aneurysms in a Multicenter Study | J Am Soc Nephrol 35, 2024: TH-PO023 | TH-PO023 | Azura Vascular Care, Renal Research Institute | Read More | Dong Z., Zhang H., Wang L.-C., Ren S., Han M., Tisdale L., Bittencourt V.G., Rosales L., Starakiewicz P., Douglas D., Shtaynberg N., Kozyra A., Fuca N., Prakash-Polet S., Thijssen S., Preddie D.C. and Kotanko P.: Validation of a Cloud-Based Convolutional Neural Network Classifying Arteriovenous Access Aneurysms in a Multicenter Study J Am Soc Nephrol 35, 2024: TH-PO023. |
19 | Feuersenger A., Roth L., Wolf M., Arkossy O., Larkin J.W., Walter J. and Arens H.-J. | Profiles of Home Medication Use in Patients on Dialysis Globally | J Am Soc Nephrol 35, 2024: FR-PO428 | FR-PO428 | Fresenius Medical Care | Read More | Feuersenger A., Roth L., Wolf M., Arkossy O., Larkin J.W., Walter J. and Arens H.-J.: Profiles of Home Medication Use in Patients on Dialysis Globally J Am Soc Nephrol 35, 2024: FR-PO428. |
20 | Filardi V., Ban A.N., Wang L.-C., Ye X., Kotanko P. and Zhang H. | Changes in Relative Blood Volume during Hemodialysis: An Extensive US Cohort | J Am Soc Nephrol 35, 2024: TH-PO321 | TH-PO321 | Renal Research Institute | Read More | Filardi V., Ban A.N., Wang L.-C., Ye X., Kotanko P. and Zhang H.: Changes in Relative Blood Volume during Hemodialysis: An Extensive US Cohort J Am Soc Nephrol 35, 2024: TH-PO321. |
21 | Fuertinger D.H., Joerg D.J., Meigel F.J. and Kotanko P. | Comorbidity Prevalence among Patients with CKD: Insights from the National Health and Nutrition Examination Survey (NHANES) | J Am Soc Nephrol 35, 2024: TH-PO1011 | TH-PO1011 | Fresenius Medical Care, Renal Research Institute | Read More | Fuertinger D.H., Joerg D.J., Meigel F.J. and Kotanko P.: Comorbidity Prevalence among Patients with CKD: Insights from the National Health and Nutrition Examination Survey (NHANES) J Am Soc Nephrol 35, 2024: TH-PO1011. |
22 | Gan L., Zhao B., Zhang L., Guo Y., Lin Q., Griesshaber B., Ho K., Stauss-Grabo M. and Zuo L. | A Randomized Controlled Clinical Trial to Evaluate the Efficacy and Safety of FX CorAL Dialyzers during Hemodialysis Treatment in Chinese Patients on Maintenance Hemodialysis: Study Protocol | J Am Soc Nephrol 35, 2024: PUB123 | PUB123 | Fresenius Medical Care | Read More | Gan L., Zhao B., Zhang L., Guo Y., Lin Q., Griesshaber B., Ho K., Stauss-Grabo M. and Zuo L.: A Randomized Controlled Clinical Trial to Evaluate the Efficacy and Safety of FX CorAL Dialyzers during Hemodialysis Treatment in Chinese Patients on Maintenance Hemodialysis: Study Protocol J Am Soc Nephrol 35, 2024: PUB123. |
23 | Gorji H., Wang L.-C., Thwin O., Chao J.E., Debure L., Grobe N., Wang X., Zhang H., Thijssen S., Wisniewski T. and Kotanko P. | Dynamics of Amyloid-β and Total Tau in Cerebrospinal Fluid and Plasma of Patients on Hemodialysis | J Am Soc Nephrol 35, 2024: SA-PO396 | SA-PO396 | Renal Research Institute | Read More | Gorji H., Wang L.-C., Thwin O., Chao J.E., Debure L., Grobe N., Wang X., Zhang H., Thijssen S., Wisniewski T. and Kotanko P.: Dynamics of Amyloid-β and Total Tau in Cerebrospinal Fluid and Plasma of Patients on Hemodialysis J Am Soc Nephrol 35, 2024: SA-PO396. |
24 | Han M., Fuentes L.R., Wang L.-C., Thwin O., Tisdale L. and Kotanko P. | How Pervasive Is Pervasive Sensing in Hemodialysis? Results from a Clinical Research Survey of Urban Dialysis Clinics | J Am Soc Nephrol 35, 2024: TH-PO275 | TH-PO275 | Renal Research Institute | Read More | Han M., Fuentes L.R., Wang L.-C., Thwin O., Tisdale L. and Kotanko P.: How Pervasive Is Pervasive Sensing in Hemodialysis? Results from a Clinical Research Survey of Urban Dialysis Clinics J Am Soc Nephrol 35, 2024: TH-PO275. |
25 | Han M., Wang Y., Tao X., Preciado P., Tisdale L., Thwin O. and Kotanko P. | Trends in Physical Activity before Hospitalization: A Prospective Observational Study in Patients on Hemodialysis Using Wearable Activity Trackers | J Am Soc Nephrol 35, 2024: TH-PO276 | TH-PO276 | Renal Research Institute | Read More | Han M., Wang Y., Tao X., Preciado P., Tisdale L., Thwin O. and Kotanko P.: Trends in Physical Activity before Hospitalization: A Prospective Observational Study in Patients on Hemodialysis Using Wearable Activity Trackers J Am Soc Nephrol 35, 2024: TH-PO276. |
26 | Hu M., Quandelacy T., Wang Y., Kotanko P. and Conway B. | Joint Modeling of Longitudinal Ferritin Trajectories and COVID-19 Infections in Native American, Hispanic, and White Patients on Hemodialysis | J Am Soc Nephrol 35, 2024: PUB173 | PUB173 | Renal Research Institute | Read More | Hu M., Quandelacy T., Wang Y., Kotanko P. and Conway B.: Joint Modeling of Longitudinal Ferritin Trajectories and COVID-19 Infections in Native American, Hispanic, and White Patients on Hemodialysis J Am Soc Nephrol 35, 2024: PUB173. |
27 | Jiao Y., Wolf M., Croft K.R., Carioni P., Soni M., Winter A., Neri L., Chaudhuri S., Singh K., Nikam M., Stuard S., Guinsburg A.M., Chatoth D.K., Hymes J.L., Koulechov K., Usvyat L.A., Larkin J.W. and Maddux F.W. | Kidney Failure Etiology and Modality Worldwide: Apollo Dial DB | J Am Soc Nephrol 35, 2024: FR-PO393 | FR-PO393 | Fresenius Medical Care | Read More | Jiao Y., Wolf M., Croft K.R., Carioni P., Soni M., Winter A., Neri L., Chaudhuri S., Singh K., Nikam M., Stuard S., Guinsburg A.M., Chatoth D.K., Hymes J.L., Koulechov K., Usvyat L.A., Larkin J.W. and Maddux F.W.: Kidney Failure Etiology and Modality Worldwide: Apollo Dial DB J Am Soc Nephrol 35, 2024: FR-PO393. |
28 | Jiao Y., Wolf M., Croft K.R., Carioni P., Soni M., Winter A., Neri L., Chaudhuri S., Singh K., Nikam M., Stuard S., Guinsburg A.M., Chatoth D.K., Hymes J.L., Koulechov K., Usvyat L.A., Larkin J.W. and Maddux F.W. | Primary Cause of Kidney Failure in 40 Countries in Apollo Dial DB | J Am Soc Nephrol 35, 2024: FR-PO338 | FR-PO338 | Fresenius Medical Care | Read More | Jiao Y., Wolf M., Croft K.R., Carioni P., Soni M., Winter A., Neri L., Chaudhuri S., Singh K., Nikam M., Stuard S., Guinsburg A.M., Chatoth D.K., Hymes J.L., Koulechov K., Usvyat L.A., Larkin J.W. and Maddux F.W.: Primary Cause of Kidney Failure in 40 Countries in Apollo Dial DB J Am Soc Nephrol 35, 2024: FR-PO338. |
29 | Jiao Y., Wolf M., Croft K.R., Carioni P., Soni M., Winter A., Neri L., Chaudhuri S., Singh K., Nikam M., Stuard S., Guinsburg A.M., Chatoth D.K., Hymes J.L., Koulechov K., Usvyat L.A., Larkin J.W. and Maddux F.W. | Regional Differences in Kidney Replacement Therapy in Diabetic Kidney Disease: Apollo Dial DB | J Am Soc Nephrol 35, 2024: FR-PO339 | FR-PO339 | Fresenius Medical Care | Read More | Jiao Y., Wolf M., Croft K.R., Carioni P., Soni M., Winter A., Neri L., Chaudhuri S., Singh K., Nikam M., Stuard S., Guinsburg A.M., Chatoth D.K., Hymes J.L., Koulechov K., Usvyat L.A., Larkin J.W. and Maddux F.W.: Regional Differences in Kidney Replacement Therapy in Diabetic Kidney Disease: Apollo Dial DB J Am Soc Nephrol 35, 2024: FR-PO339. |
30 | Joerg D.J., Fuertinger D.H., Hippen B.E. and Kotanko P. | Model-Based Inference of the Living-to-Deceased-Donor Ratio among Living Kidney Transplant Patients in the United States | J Am Soc Nephrol 35, 2024: TH-PO776 | TH-PO776 | Fresenius Medical Care, Renal Research Institute | Read More | Joerg D.J., Fuertinger D.H., Hippen B.E. and Kotanko P.: Model-Based Inference of the Living-to-Deceased-Donor Ratio among Living Kidney Transplant Patients in the United States J Am Soc Nephrol 35, 2024: TH-PO776. |
31 | Kuharic M., Hurt C.N., Fowler K.J., Bastian A.W., Beck J., Berg E.J.v.d. and Peipert J.D. | Burden of BK Virus Infection and BK Virus-Associated Nephropathy in Kidney Transplant Recipients: Scoping Review Reveals Gaps in Patient- Centered Research | J Am Soc Nephrol 35, 2024: SA-PO1000 | SA-PO1000 | Memo Therapeutics | Read More | Kuharic M., Hurt C.N., Fowler K.J., Bastian A.W., Beck J., Berg E.J.v.d. and Peipert J.D.: Burden of BK Virus Infection and BK Virus-Associated Nephropathy in Kidney Transplant Recipients: Scoping Review Reveals Gaps in Patient- Centered Research J Am Soc Nephrol 35, 2024: SA-PO1000. |
32 | Lama S.K., Larkin J.W., Chaudhuri S., Jiao Y., Winter A., Stauss-Grabo M., Usvyat L.A., Hymes J.L., Maddux F.W., Wheeler D.C., Stenvinkel P., Floege J. On behalf of the INSPIRE Core Group | Prediction of Gastrointestinal Bleeding Hospitalization Risk in Hemodialysis: Machine Learning vs. Logistic Regression | J Am Soc Nephrol 35, 2024: FR-PO414 | FR-PO414 | Fresenius Medical Care | Read More | Lama S.K., Larkin J.W., Chaudhuri S., Jiao Y., Winter A., Stauss-Grabo M., Usvyat L.A., Hymes J.L., Maddux F.W., Wheeler D.C., Stenvinkel P., Floege J. On behalf of the INSPIRE Core Group: Prediction of Gastrointestinal Bleeding Hospitalization Risk in Hemodialysis: Machine Learning vs. Logistic Regression J Am Soc Nephrol 35, 2024: FR-PO414. |
33 | Leal D.V., Cardoso D.F., Andrade F.P., Martins P.M., Ferreira M.A., Baker L.A., Smith A.C. and Viana J.L. | Do Baseline Parathyroid Hormone Levels Influence the Effect of Intradialytic Exercise on Bone Turnover Markers in Patients on Haemodialysis? | J Am Soc Nephrol 35, 2024: TH-PO279 | TH-PO279 | Nephrocare | Read More | Leal D.V., Cardoso D.F., Andrade F.P., Martins P.M., Ferreira M.A., Baker L.A., Smith A.C. and Viana J.L.: Do Baseline Parathyroid Hormone Levels Influence the Effect of Intradialytic Exercise on Bone Turnover Markers in Patients on Haemodialysis? J Am Soc Nephrol 35, 2024: TH-PO279. |
34 | Malhotra R., Larsen B., Dasgupta S., Chopra T., Schrauben S.J., Drew D.A., Ikizler T.A., Kotanko P. and Ix J.H. | Fragmented Physical Activity and Mortality in Patients on Hemodialysis: Insights from the Fitbit Study | J Am Soc Nephrol 35, 2024: TH-PO288 | TH-PO288 | Renal Research Institute | Read More | Malhotra R., Larsen B., Dasgupta S., Chopra T., Schrauben S.J., Drew D.A., Ikizler T.A., Kotanko P. and Ix J.H.: Fragmented Physical Activity and Mortality in Patients on Hemodialysis: Insights from the Fitbit Study J Am Soc Nephrol 35, 2024: TH-PO288. |
35 | Mallamaci F., Torino C., Sarafidis P., Ekart R., Balafa O., Giudice A.M.D., Aucella F., Morosetti M., Tripepi R., Marino C., Tripepi G. and Zoccali C. | Prevalence and Risk Factors of Altered Control of BP during the Night in a Large Hemodialysis Population Evaluated by 48-Hour Ambulatory BP Monitoring | J Am Soc Nephrol 35, 2024: FR-PO362 | FR-PO362 | Renal Research Institute | Read More | Mallamaci F., Torino C., Sarafidis P., Ekart R., Balafa O., Giudice A.M.D., Aucella F., Morosetti M., Tripepi R., Marino C., Tripepi G. and Zoccali C.: Prevalence and Risk Factors of Altered Control of BP during the Night in a Large Hemodialysis Population Evaluated by 48-Hour Ambulatory BP Monitoring J Am Soc Nephrol 35, 2024: FR-PO362. |
36 | Mallamaci F., Torino C., Sarafidis P., Ekart R., Balafa O., Giudice A.M.D., Aucella F., Morosetti M., Tripepi R., Marino C., Tripepi G. and Zoccali C. | Isolated Diastolic Hypertension in Patients on Hemodialysis | J Am Soc Nephrol 35, 2024: FR-PO363 | FR-PO363 | Renal Research Institute | Read More | Mallamaci F., Torino C., Sarafidis P., Ekart R., Balafa O., Giudice A.M.D., Aucella F., Morosetti M., Tripepi R., Marino C., Tripepi G. and Zoccali C.: Isolated Diastolic Hypertension in Patients on Hemodialysis J Am Soc Nephrol 35, 2024: FR-PO363. |
37 | McIntyre C.W., Deleaval P., Penny J.D. and Freeman A. | Initial Evaluation of Sodium-Free Intraperitoneal 30% Icodextrin/ 10% Dextrose Solution to Test Short-Term Safety, Tolerability, and Preliminary Efficacy | J Am Soc Nephrol 35, 2024: TH-OR67 | TH-OR67 | Nephrocare | Read More | McIntyre C.W., Deleaval P., Penny J.D. and Freeman A.: Initial Evaluation of Sodium-Free Intraperitoneal 30% Icodextrin/ 10% Dextrose Solution to Test Short-Term Safety, Tolerability, and Preliminary Efficacy J Am Soc Nephrol 35, 2024: TH-OR67. |
38 | Meigel F.J., Ho K., Kotanko P. and Fuertinger D.H. | In Patients on Hemodialysis, Relative Blood Volume Ranges Related to Improved Survival Are Associated with Increased Volume Reductions in Vascular and Interstitial Spaces | J Am Soc Nephrol 35, 2024: SA-PO419 | SA-PO419 | Fresenius Medical Care, Renal Research Institute | Read More | Meigel F.J., Ho K., Kotanko P. and Fuertinger D.H.: In Patients on Hemodialysis, Relative Blood Volume Ranges Related to Improved Survival Are Associated with Increased Volume Reductions in Vascular and Interstitial Spaces J Am Soc Nephrol 35, 2024: SA-PO419. |
39 | Meijiao Zhou, Linda Ficociello, Hao Han and Anger M.S. | Managing Hyperphosphatemia in Patients on Hemodialysis: A Comparison of Sucroferric Oxyhydroxide (SO) Monotherapy and Tenapanor with Other Non-SO Phosphate Binders | J Am Soc Nephrol 35, 2024: TH-PO167 | TH-PO167 | Fresenius Medical Care | Read More | Meijiao Zhou, Linda Ficociello, Hao Han and Anger M.S.: Managing Hyperphosphatemia in Patients on Hemodialysis: A Comparison of Sucroferric Oxyhydroxide (SO) Monotherapy and Tenapanor with Other Non-SO Phosphate Binders J Am Soc Nephrol 35, 2024: TH-PO167. |
40 | Mermelstein A.E., Kovacevic T., Hymes J.L., Wang Y., Raimann J.G. and Kotanko P. | Hemoglobin (hgb) Target Range Associated with All-Cause Repeated Hospitalization in Patients on Hemodialysis Treated with Mircera | J Am Soc Nephrol 35, 2024: FR-PO398 | FR-PO398 | Fresenius Medical Care, Renal Research Institute, Vifor Fresenius Medical Care Renal Pharma | Read More | Mermelstein A.E., Kovacevic T., Hymes J.L., Wang Y., Raimann J.G. and Kotanko P.: Hemoglobin (hgb) Target Range Associated with All-Cause Repeated Hospitalization in Patients on Hemodialysis Treated with Mircera J Am Soc Nephrol 35, 2024: FR-PO398. |
41 | Mermelstein A.E., Kovacevic T., Wang Y., Fuertinger D.H., Hymes J.L., Raimann J.G. and Kotanko P. | Association of Risk of Death and Hemoglobin (hgb) Variability in Anemia Management of Patients on Hemodialysis | J Am Soc Nephrol 35, 2024: FR-PO397 | FR-PO397 | Fresenius Medical Care, Renal Research Institute, Vifor Fresenius Medical Care Renal Pharma | Read More | Mermelstein A.E., Kovacevic T., Wang Y., Fuertinger D.H., Hymes J.L., Raimann J.G. and Kotanko P.: Association of Risk of Death and Hemoglobin (hgb) Variability in Anemia Management of Patients on Hemodialysis J Am Soc Nephrol 35, 2024: FR-PO397. |
42 | Michael A. Kraus, Carol Lee, Amanda Stennett, Lisa E. Koenig, Rheannon Smith, Linda Ficociello, Dinesh K. Chatoth and Hymes J.L. | Outcomes of Patients with Nonkidney Medical Therapies Dialyzed at Chronic Hemodialysis Centers | J Am Soc Nephrol 35, 2024: FR-PO418 | FR-PO418 | Fresenius Medical Care | Read More | Michael A. Kraus, Carol Lee, Amanda Stennett, Lisa E. Koenig, Rheannon Smith, Linda Ficociello, Dinesh K. Chatoth and Hymes J.L.: Outcomes of Patients with Nonkidney Medical Therapies Dialyzed at Chronic Hemodialysis Centers J Am Soc Nephrol 35, 2024: FR-PO418. |
43 | Moreno-Amaral A.N., Dias E.S., Monte-Alegre J.B., Spitzenbergen B.A.K.V., Andrade G.B., Brugnolo-Santos V.A., Ozogovski Y.D., Dias G.F., Grobe N., Kotanko P. and Moraes T.P. | Exploring the Interplay of Inflammation, Eryptosis, and Anemia in ESKD | J Am Soc Nephrol 35, 2024: TH-PO878 | TH-PO878 | Renal Research Institute | Read More | Moreno-Amaral A.N., Dias E.S., Monte-Alegre J.B., Spitzenbergen B.A.K.V., Andrade G.B., Brugnolo-Santos V.A., Ozogovski Y.D., Dias G.F., Grobe N., Kotanko P. and Moraes T.P.: Exploring the Interplay of Inflammation, Eryptosis, and Anemia in ESKD J Am Soc Nephrol 35, 2024: TH-PO878. |
44 | Navarro A.Y., Perez A. and Lino R.J. | Determination of Fracture Risk in a Hemodialysis Unit in Ecuador Using the FRAX Tool without Bone Mineral Density (BMD) | J Am Soc Nephrol 35, 2024: PUB129 | PUB129 | Fresenius Medical Care | Read More | Navarro A.Y., Perez A. and Lino R.J.: Determination of Fracture Risk in a Hemodialysis Unit in Ecuador Using the FRAX Tool without Bone Mineral Density (BMD) J Am Soc Nephrol 35, 2024: PUB129. |
45 | Navarro A.Y., Perez A. and Lino R.J. | Prevalence of the Chronic Inflammatory State and Relationship with Prealbumin and Morbimortality in Patients with CKD | J Am Soc Nephrol 35, 2024: PUB130 | PUB130 | Fresenius Medical Care | Read More | Navarro A.Y., Perez A. and Lino R.J.: Prevalence of the Chronic Inflammatory State and Relationship with Prealbumin and Morbimortality in Patients with CKD J Am Soc Nephrol 35, 2024: PUB130. |
46 | Oliva A.E., Raimann J.G., Mermelstein A.E., Ban A.N., Plascencia Y., Medeiros M., Cisneros A., Chavez J. and Garcia-Garcia G. | Decreasing Trends in Pediatric Kidney Transplantation in Mexico, 2007-2023 | J Am Soc Nephrol 35, 2024: TH-PO815 | TH-PO815 | Renal Research Institute | Read More | Oliva A.E., Raimann J.G., Mermelstein A.E., Ban A.N., Plascencia Y., Medeiros M., Cisneros A., Chavez J. and Garcia-Garcia G.: Decreasing Trends in Pediatric Kidney Transplantation in Mexico, 2007-2023 J Am Soc Nephrol 35, 2024: TH-PO815. |
47 | Pang H.H., Gu L., Zuo L., Ding J., Wang L., Zhang H., Wang L., Maierhofer A., Braun J., Stauss-Grabo M., Qi W., Lin Q., Guo Y. and Ho K. | Controlling Sodium Balance in Maintenance Hemodialysis (MHD) Treatment: Study Protocol of a Randomized Controlled Registration Trial | J Am Soc Nephrol 35, 2024: SA-PO412 | SA-PO412 | Fresenius Medical Care | Read More | Pang H.H., Gu L., Zuo L., Ding J., Wang L., Zhang H., Wang L., Maierhofer A., Braun J., Stauss-Grabo M., Qi W., Lin Q., Guo Y. and Ho K.: Controlling Sodium Balance in Maintenance Hemodialysis (MHD) Treatment: Study Protocol of a Randomized Controlled Registration Trial J Am Soc Nephrol 35, 2024: SA-PO412. |
48 | Penny J.D., Deleaval P. and McIntyre C.W. | Dedicated Patient Optimization Program Improves Lives of Vulnerable Patients | J Am Soc Nephrol 35, 2024: TH-PO299 | TH-PO299 | Nephrocare | Read More | Penny J.D., Deleaval P. and McIntyre C.W.: Dedicated Patient Optimization Program Improves Lives of Vulnerable Patients J Am Soc Nephrol 35, 2024: TH-PO299. |
49 | Qi W., Hwang W.M., Ahn S.-Y., Lee Y.-K., Shin B.C., Lee J.h., Kim S.G., Kim H.-J., Stauss-Grabo M., So C. and Feuersenger A. | A Postmarketing Study Assessing Safety and Efficacy of Velphoro in Korean Adult Dialysis Patients | J Am Soc Nephrol 35, 2024: TH-PO171 | TH-PO171 | Fresenius Medical Care | Read More | Qi W., Hwang W.M., Ahn S.-Y., Lee Y.-K., Shin B.C., Lee J.h., Kim S.G., Kim H.-J., Stauss-Grabo M., So C. and Feuersenger A.: A Postmarketing Study Assessing Safety and Efficacy of Velphoro in Korean Adult Dialysis Patients J Am Soc Nephrol 35, 2024: TH-PO171. |
50 | Rigodon V., Hartley B., Pecoits P.G., Larkin J.W., Jiao Y., Neri L., Usvyat L.A., Chatoth D.K., Hymes J.L., Maddux F.W., Kooman J., Moraes T.P., Barretti P., Kotanko P., Pecoits-Filho R. and Guedes M.H. | Iron Deficiency Increases Mortality Risk among Incident Peritoneal Dialysis Patients | J Am Soc Nephrol 35, 2024: TH-OR66 | TH-OR66 | Fresenius Medical Care, Renal Research Institute | Read More | Rigodon V., Hartley B., Pecoits P.G., Larkin J.W., Jiao Y., Neri L., Usvyat L.A., Chatoth D.K., Hymes J.L., Maddux F.W., Kooman J., Moraes T.P., Barretti P., Kotanko P., Pecoits-Filho R. and Guedes M.H.: Iron Deficiency Increases Mortality Risk among Incident Peritoneal Dialysis Patients J Am Soc Nephrol 35, 2024: TH-OR66. |
51 | Rigodon V., Jiao Y., Guedes M.H., Tiv S., Peters V., Wolf M., Croft K.R., Carioni P., Winter A., Neri L., Chaudhuri S., Nikam M., Toffelmire E.B., Konings C., Stuard S., Hussein R.H., Guinsburg A.M., Pecoits-Filho R., Moraes T.P., Raimann J.G., Ye X., Larkin J.W. and Kotanko P. | Etiology of Kidney Failure across the World in MONitoring Dialysis Outcomes (MONDO) Dataset | J Am Soc Nephrol 35, 2024: FR-PO394 | FR-PO394 | Fresenius Medical Care, Renal Research Institute | Read More | Rigodon V., Jiao Y., Guedes M.H., Tiv S., Peters V., Wolf M., Croft K.R., Carioni P., Winter A., Neri L., Chaudhuri S., Nikam M., Toffelmire E.B., Konings C., Stuard S., Hussein R.H., Guinsburg A.M., Pecoits-Filho R., Moraes T.P., Raimann J.G., Ye X., Larkin J.W. and Kotanko P.: Etiology of Kidney Failure across the World in MONitoring Dialysis Outcomes (MONDO) Dataset J Am Soc Nephrol 35, 2024: FR-PO394. |
52 | Ríos T.D.l., Garcia I., Schmitt J., Stauss-Grabo M. and Atiye S. | Influence of Variable Inflow Volume, Dwell Duration, and Dialysate Glucose Concentration on Ultrafiltration Volume in Patients on Automated Peritoneal Dialysis: pPD Study | J Am Soc Nephrol 35, 2024: PUB190 | PUB190 | Fresenius Medical Care | Read More | Ríos T.D.l., Garcia I., Schmitt J., Stauss-Grabo M. and Atiye S.: Influence of Variable Inflow Volume, Dwell Duration, and Dialysate Glucose Concentration on Ultrafiltration Volume in Patients on Automated Peritoneal Dialysis: pPD Study J Am Soc Nephrol 35, 2024: PUB190. |
53 | Ronova P., Krizsh M., Griesshaber B., Erlenkoetter A., Zawada A.M., Nitschel R., Ottillinger B., Zhao B., Korolev N., Braun J., Larkin J.W. and Stauss-Grabo M. | Increased Dialyzer Membrane Hydrophilicity Improves Hemocompatibility and Performance: A Randomized Investigation | J Am Soc Nephrol 35, 2024: TH-PO242 | TH-PO242 | Fresenius Medical Care, Nephrocare | Read More | Ronova P., Krizsh M., Griesshaber B., Erlenkoetter A., Zawada A.M., Nitschel R., Ottillinger B., Zhao B., Korolev N., Braun J., Larkin J.W. and Stauss-Grabo M.: Increased Dialyzer Membrane Hydrophilicity Improves Hemocompatibility and Performance: A Randomized Investigation J Am Soc Nephrol 35, 2024: TH-PO242. |
54 | Schmitt J., Gillen C., Erlenkoetter A., Rauber L., Derlet-Savoia A. and Stauss-Grabo M. | Clinical Performance of the New Plasma Filter PX2 in Therapeutic Plasma Exchange | J Am Soc Nephrol 35, 2024: PUB132 | PUB132 | Fresenius Medical Care | Read More | Schmitt J., Gillen C., Erlenkoetter A., Rauber L., Derlet-Savoia A. and Stauss-Grabo M.: Clinical Performance of the New Plasma Filter PX2 in Therapeutic Plasma Exchange J Am Soc Nephrol 35, 2024: PUB132. |
55 | Schmitt J., Gorrin M.R., Ríos T.D.l. and Stauss-Grabo M. | Clinical Performance of the Therapy Option FlexPoint (Flexible Volume and Dwell Time Management) of the PD Cycler Sleep Safe Harmony | J Am Soc Nephrol 35, 2024: PUB195 | PUB195 | Fresenius Medical Care | Read More | Schmitt J., Gorrin M.R., Ríos T.D.l. and Stauss-Grabo M.: Clinical Performance of the Therapy Option FlexPoint (Flexible Volume and Dwell Time Management) of the PD Cycler Sleep Safe Harmony J Am Soc Nephrol 35, 2024: PUB195. |
56 | Shivakumar O., Ye X., Larkin J.W., Kotanko P., Hippen B.E., Guinsburg A.M., Raimann J.G., Ashby D., Tam F.W. and Ashrafian H. | Dialysis after Graft Loss: Preliminary Findings of a Large Multinational Database | J Am Soc Nephrol 35, 2024: FR-PO421 | FR-PO421 | Fresenius Medical Care, Renal Research Institute | Read More | Shivakumar O., Ye X., Larkin J.W., Kotanko P., Hippen B.E., Guinsburg A.M., Raimann J.G., Ashby D., Tam F.W. and Ashrafian H.: Dialysis after Graft Loss: Preliminary Findings of a Large Multinational Database J Am Soc Nephrol 35, 2024: FR-PO421. |
57 | Sinha S., Nigwekar S.U., Gould L., Serena T.E., Moe S.M., Aronoff G.R., Chatoth D.K., Hymes J.L., Lehrer G.A., Keller L.H., Gold A., Szecsödy P., Radewonuk J., Perelló J. and Chertow G.M. | Reduction of Calciphylaxis-Related Infections with Hexasodium Fytate Treatment in a Randomized, Double-Blind, Phase 3, Placebo-Controlled Trial | J Am Soc Nephrol 35, 2024: FR-OR27 | FR-OR27 | Fresenius Medical Care | Read More | Sinha S., Nigwekar S.U., Gould L., Serena T.E., Moe S.M., Aronoff G.R., Chatoth D.K., Hymes J.L., Lehrer G.A., Keller L.H., Gold A., Szecsödy P., Radewonuk J., Perelló J. and Chertow G.M.: Reduction of Calciphylaxis-Related Infections with Hexasodium Fytate Treatment in a Randomized, Double-Blind, Phase 3, Placebo-Controlled Trial J Am Soc Nephrol 35, 2024: FR-OR27. |
58 | Spitzenbergen B.A.K.V., Dias E.S., Monte-Alegre J.B., Andrade G.B., Brugnolo-Santos V.A., Ozogovski Y.D., Dias G.F., Grobe N., Kotanko P. and Moreno-Amaral A.N. | Protein-Bound Uremic Solute 3-Carboxy-4-Methyl-5-Propyl-2-Furanpropanoic Acid (CMPF) Induces Eryptosis through a Piezo1-Dependent Pathway | J Am Soc Nephrol 35, 2024: TH-PO882 | TH-PO882 | Renal Research Institute | Read More | Spitzenbergen B.A.K.V., Dias E.S., Monte-Alegre J.B., Andrade G.B., Brugnolo-Santos V.A., Ozogovski Y.D., Dias G.F., Grobe N., Kotanko P. and Moreno-Amaral A.N.: Protein-Bound Uremic Solute 3-Carboxy-4-Methyl-5-Propyl-2-Furanpropanoic Acid (CMPF) Induces Eryptosis through a Piezo1-Dependent Pathway J Am Soc Nephrol 35, 2024: TH-PO882. |
59 | Tan W., Wen H.H., Wang L.-C., Dong Z., Tisdale L., Thijssen S., Kotanko P., Nadkarni G.N. and Chan L. | High Prevalence and Inequities in Unmet Social Risk in Diverse Urban Patients on Hemodialysis | J Am Soc Nephrol 35, 2024: TH-PO855 | TH-PO855 | Renal Research Institute | Read More | Tan W., Wen H.H., Wang L.-C., Dong Z., Tisdale L., Thijssen S., Kotanko P., Nadkarni G.N. and Chan L.: High Prevalence and Inequities in Unmet Social Risk in Diverse Urban Patients on Hemodialysis J Am Soc Nephrol 35, 2024: TH-PO855. |
60 | Titapiccolo J.I., Nikam M., Mooppil N., Singh T., Gualdoni A., Hymes J.L., Larkin J.W., Usvyat L.A., Bellocchio F., Neri L. and Yeung J. | Clinical Implementation Framework of Anemia Control Model in Singapore | J Am Soc Nephrol 35, 2024: TH-PO918 | TH-PO918 | Fresenius Medical Care | Read More | Titapiccolo J.I., Nikam M., Mooppil N., Singh T., Gualdoni A., Hymes J.L., Larkin J.W., Usvyat L.A., Bellocchio F., Neri L. and Yeung J.: Clinical Implementation Framework of Anemia Control Model in Singapore J Am Soc Nephrol 35, 2024: TH-PO918. |
61 | Titapiccolo J.I., Nikam M., Stuard S., Hymes J.L., Larkin J.W., Lama S.K., Chaudhuri S., Bellocchio F., Yeung J., Usvyat L.A. and Neri L. | Performance and Global Integration in Clinical Practice of a Fistula Failure Risk-Estimate Tool Based on Artificial Intelligence (AI) | J Am Soc Nephrol 35, 2024: TH-OR27 | TH-OR27 | Fresenius Medical Care | Read More | Titapiccolo J.I., Nikam M., Stuard S., Hymes J.L., Larkin J.W., Lama S.K., Chaudhuri S., Bellocchio F., Yeung J., Usvyat L.A. and Neri L.: Performance and Global Integration in Clinical Practice of a Fistula Failure Risk-Estimate Tool Based on Artificial Intelligence (AI) J Am Soc Nephrol 35, 2024: TH-OR27. |
62 | Wammi A.P., Kluge S., Jarczak D., Willam C., Blaas S.H., Ottillinger B., Korolev N., Braun J. and Stauss-Grabo M. | Safety and Efficiency Evaluation of Carbon Dioxide Removal in Combination with Continuous Veno-Venous Hemodialysis/ Hemodiafiltration Therapy: Baseline Characteristics of the multiECCO2R Study | J Am Soc Nephrol 35, 2024: SA-PO045 | SA-PO045 | Fresenius Medical Care | Read More | Wammi A.P., Kluge S., Jarczak D., Willam C., Blaas S.H., Ottillinger B., Korolev N., Braun J. and Stauss-Grabo M.: Safety and Efficiency Evaluation of Carbon Dioxide Removal in Combination with Continuous Veno-Venous Hemodialysis/ Hemodiafiltration Therapy: Baseline Characteristics of the multiECCO2R Study J Am Soc Nephrol 35, 2024: SA-PO045. |
63 | Wang L.-C., Ban A.N., Filardi V., Ye X., Kotanko P. and Zhang H. | Changes of Arterial Oxygen Saturation during Hemodialysis | J Am Soc Nephrol 35, 2024: PUB163 | PUB163 | Renal Research Institute | Read More | Wang L.-C., Ban A.N., Filardi V., Ye X., Kotanko P. and Zhang H.: Changes of Arterial Oxygen Saturation during Hemodialysis J Am Soc Nephrol 35, 2024: PUB163. |
64 | Wang L.-C., Fuentes L.R., Mermelstein A.E., Zhang H., Moissl U., Raimann J.G., Thijssen S., Sande F.v.d., Kooman J. and Kotanko P. | Relationship between Fluid Overload and Anemia in the US Hemodialysis Population | J Am Soc Nephrol 35, 2024: SA-PO420 | SA-PO420 | Fresenius Medical Care, Renal Research Institute | Read More | Wang L.-C., Fuentes L.R., Mermelstein A.E., Zhang H., Moissl U., Raimann J.G., Thijssen S., Sande F.v.d., Kooman J. and Kotanko P.: Relationship between Fluid Overload and Anemia in the US Hemodialysis Population J Am Soc Nephrol 35, 2024: SA-PO420. |
65 | Wang X., Absar H., Grobe N., Kakembo M., Wang X., Dias G.F., Tisdale L., Zhu F., Rosales L., Wang L.-C., Han M. and Kotanko P. | Metabolomic Analysis of Peritoneal Dialysis Effluent across Different Peritoneal Transport Types | J Am Soc Nephrol 35, 2024: SA-PO440 | SA-PO440 | Renal Research Institute | Read More | Wang X., Absar H., Grobe N., Kakembo M., Wang X., Dias G.F., Tisdale L., Zhu F., Rosales L., Wang L.-C., Han M. and Kotanko P.: Metabolomic Analysis of Peritoneal Dialysis Effluent across Different Peritoneal Transport Types J Am Soc Nephrol 35, 2024: SA-PO440. |
66 | Wang X., Zaidi S.S., Chan C., Cheung Y.Y., Grobe N., Kotanko P., Mitra S. and Nikam M. | Presurgery Plasma Metabolites Are Associated with Arteriovenous Fistula Maturation Outcomes | J Am Soc Nephrol 35, 2024: FR-PO517 | FR-PO517 | Fresenius Medical Care, Renal Research Institute | Read More | Wang X., Zaidi S.S., Chan C., Cheung Y.Y., Grobe N., Kotanko P., Mitra S. and Nikam M.: Presurgery Plasma Metabolites Are Associated with Arteriovenous Fistula Maturation Outcomes J Am Soc Nephrol 35, 2024: FR-PO517. |
67 | Wolf M., Ficociello L., Zhou M., Usvyat L.A., Stuard S., Hymes J.L. and Maddux F.W. | Changes in Fluid Overload during the First 6 Months of Dialysis among More than 13,000 Patients | J Am Soc Nephrol 35, 2024: SA-PO423 | SA-PO423 | Fresenius Medical Care | Read More | Wolf M., Ficociello L., Zhou M., Usvyat L.A., Stuard S., Hymes J.L. and Maddux F.W.: Changes in Fluid Overload during the First 6 Months of Dialysis among More than 13,000 Patients J Am Soc Nephrol 35, 2024: SA-PO423. |
68 | Ye X., Alvarez-Elias A.C., Hussein R.H., Filler G., Ferris M.E., Kotanko P. MONDO Initiative | Survival Sex Differences among Pediatric and Young Adult Hemodialysis Patients in the Global MONDO Registry | J Am Soc Nephrol 35, 2024: TH-PO265 | TH-PO265 | Renal Research Institute | Read More | Ye X., Alvarez-Elias A.C., Hussein R.H., Filler G., Ferris M.E., Kotanko P. MONDO Initiative: Survival Sex Differences among Pediatric and Young Adult Hemodialysis Patients in the Global MONDO Registry J Am Soc Nephrol 35, 2024: TH-PO265. |
69 | Yetman H., Wen H.H., Wang L.-C., Dong Z., Tisdale L., Foby Y., Olagoke M.M., Thijssen S., Kotanko P., Nadkarni G.N. and Chan L. | Social Risk Factors and Quality of Life in Patients on Hemodialysis | J Am Soc Nephrol 35, 2024: FR-PO1037 | FR-PO1037 | Renal Research Institute | Read More | Yetman H., Wen H.H., Wang L.-C., Dong Z., Tisdale L., Foby Y., Olagoke M.M., Thijssen S., Kotanko P., Nadkarni G.N. and Chan L.: Social Risk Factors and Quality of Life in Patients on Hemodialysis J Am Soc Nephrol 35, 2024: FR-PO1037. |
70 | Yi J., Zhu F., Rosales L., Tisdale L., Villarama M., Bittencourt V.G., Murphy B.M., Golnabi A. and Kotanko P. | Assessment of Body Composition by Whole-Body Bioimpedance and Body Cardio Scale in Patients on Peritoneal Dialysis | J Am Soc Nephrol 35, 2024: SA-PO489 | SA-PO489 | Renal Research Institute | Read More | Yi J., Zhu F., Rosales L., Tisdale L., Villarama M., Bittencourt V.G., Murphy B.M., Golnabi A. and Kotanko P.: Assessment of Body Composition by Whole-Body Bioimpedance and Body Cardio Scale in Patients on Peritoneal Dialysis J Am Soc Nephrol 35, 2024: SA-PO489. |
71 | Yuen T., Pham N., Ho K., Stauss-Grabo M., Strippoli G., Cromm K. CONVINCE Scientific Committee and CONVINCE Investigators | Representativeness of Populations Recruited in Randomized Controlled Trials of Hemodiafiltration vs. Hemodialysis: A Systematic Analysis in Comparison with Representative Registry Data | J Am Soc Nephrol 35, 2024: FR-PO435 | FR-PO435 | Fresenius Medical Care | Read More | Yuen T., Pham N., Ho K., Stauss-Grabo M., Strippoli G., Cromm K. CONVINCE Scientific Committee and CONVINCE Investigators: Representativeness of Populations Recruited in Randomized Controlled Trials of Hemodiafiltration vs. Hemodialysis: A Systematic Analysis in Comparison with Representative Registry Data J Am Soc Nephrol 35, 2024: FR-PO435. |
72 | Zaidi S.S., Chan C., Wang X., Cheung Y.Y., Grobe N., Kotanko P., Mitra S. and Nikam M. | Use of Early Ultrasound Scan to Predict Arteriovenous Fistula Maturation | J Am Soc Nephrol 35, 2024: FR-PO519 | FR-PO519 | Fresenius Medical Care, Renal Research Institute | Read More | Zaidi S.S., Chan C., Wang X., Cheung Y.Y., Grobe N., Kotanko P., Mitra S. and Nikam M.: Use of Early Ultrasound Scan to Predict Arteriovenous Fistula Maturation J Am Soc Nephrol 35, 2024: FR-PO519. |
73 | Zhang Y., Winter A., Alejos B., Carioni P., Arkossy O., Usvyat L.A. and Maddux F.W. | Real-World Evidence on Hemodialysis Modality and Hospitalization Outcomes | J Am Soc Nephrol 35, 2024: FR-OR19 | FR-OR19 | Fresenius Medical Care | Read More | Zhang Y., Winter A., Alejos B., Carioni P., Arkossy O., Usvyat L.A. and Maddux F.W.: Real-World Evidence on Hemodialysis Modality and Hospitalization Outcomes J Am Soc Nephrol 35, 2024: FR-OR19. |
74 | Zhu F., Abbas S.R., Rosales L. and Kotanko P. | Identification of Body Fluid Distribution in Patients on Hemodialysis and Peritoneal Dialysis Using Whole-Body and Segmental Bioimpedance Analysis | J Am Soc Nephrol 35, 2024: SA-PO449 | SA-PO449 | Renal Research Institute | Read More | Zhu F., Abbas S.R., Rosales L. and Kotanko P.: Identification of Body Fluid Distribution in Patients on Hemodialysis and Peritoneal Dialysis Using Whole-Body and Segmental Bioimpedance Analysis J Am Soc Nephrol 35, 2024: SA-PO449. |